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Abstract 
 
Efficiency of Advanced Membrane Wastewater Treatment Plant towards 
Removal of Aspirin, Salicylic acid, Paracetamol and p-Aminophenol 
 
The membrane separation technology for wastewater treatment was studied to check its 
efficiency in removing pharmaceuticals, their degradation products, and their metabolites 
from wastewater. Aspirin and paracetamol were found to degrade in wastewater furnishing 
salicylic acid and p-aminophenol, respectively. The kinetics for the degradation reactions of 
both drugs (Aspirin and Paracetamol) were investigated in wastewater environment and both 
have shown first order kinetics with rate constants 0.845 x 10
-8
 Ms
-1
 and 1.0 x 10-8 Ms-1 at 
room temperature, respectively. These values are an order of magnitude larger than those 
obtained in pure water under the same conditions. The overall performance of the plant has 
shown complete removal of these compounds from spiked wastewater within the detection 
limit of the analytical method. The most effective components for removing those drugs 
within the plant were activated carbon adsorbent and clay-micelle complex. The adsorption 
isotherms for these compounds have been studied using both activated carbon adsorbent and 
newly developed adsorbent named clay-micelle complex. All studied isotherms were found to 
fit Langmuir isotherm. The Langmuir constant and the adsorption capacity were evaluated and 
discussed.  
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Chapter One 
 
Introduction 
 
1.1 Background 
 
In the Middle East, in general, and Palestine, in particular, water resources are very limited 
and currently a serious shortage problem exists [1-3]. This situation would be aggravated in 
the future since the water balance gap between the available water supplies and the water 
demand, as a result of population growth, rapid urbanization and industrialization associated 
with living standards improvement, will increase. This gap cause serious shortage of fresh 
water to be used in human purposes, agricultural, and other non-human purposes, Hence, 
water contamination and the production of large volume of wastewater are the expected 
results [3-6]. 
In Palestine, which is a semi-arid country, water is used for domestic, industrial, and 
agricultural purposes. Historically, agriculture plays an important role in Palestinian economy 
and life, and is the main water-consuming sector. The agricultural demand of water is 
estimated to be 70% of the total water  
consumption, while 27% of water is used for domestic needs and only 3% is used for 
industrial sector [2, 4, 7]. The principal fresh water resources available to Palestinians include 
groundwater, surface water, and springs. 
 
Additional water sources include rainwater harvesting. Groundwater and springs are the main 
source of fresh water in Palestine [1, 4, 7-8]. The West Bank aquifer system has three major 
drainage basins, the Western, the Northeastern, and the Eastern basins. The first two basins 
are shared between the West Bank and Israel. The Eastern basin falls entirely within the West 
Bank. Compared to groundwater, surface water is the minor importance in the West Bank. 
The only source of surface water in the area is the Jordan River; Palestinian access to fresh 
surface water from the Jordan River is almost zero because Israel’s control of the flow of the 
river [1, 8]. 
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Therefore, water must be used wisely and efficiently not only to control the consumptive use 
of water but also to reduce the wastewater flows. Due to the expected increase in volume of 
wastewater in combination with a serious problem from its disposal, treatment and recycling 
of wastewater is critical when looking for new sources of water in water-scarce regions 
(Figure 1-1). Hence, wastewater flows must be managed effectively to prevent pollution and 
to protect the environment from hazardous chemical and biological pollutants. The purpose of 
wastewater treatment is generally to allow human and industrial effluents to be disposed 
without causing a danger neither to human health nor to the environment. 
The reuse of reclaimed wastewater in Palestine is a major priority, as confirmed by the 
Palestinian Water Policy recently adopted by the Palestinian Water Authority (PWA) and the 
Ministry of Agriculture [4, 7]. In addition, the Palestinian National Authority (PNA) has 
concern for the protection of the environment through the Ministry of Environmental Affairs 
(MEnA) [4]. 
 
 
 
 
 
 
Figure 1-1: Future approaches of dealing with water. 
 
1.1.1 Wastewater management in Palestine 
 
Wastewater is one of the major sources of pollution that has serious adverse impact both on 
the environment and local residents. The wastewater sector status in Palestine is characterized 
by poor sanitation, different wastewater quality, insufficient treatment, and unsafe disposal of 
untreated or partially treated wastewater into the environment. Sewage collection networks in 
the West Bank are limited to major cities and to certain portions of these municipalities. Most 
of them are poorly designed and old [4, 9]. Therefore, the situation of the sewerage system is 
extremely critical [10]. Wastewater management in Palestine had been neglected for decades. 
Water Use Minimum Disposal Treatment 
Recycling 
Reuse 
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Meanwhile, wastewater management is a tool to maintain environmental integrity, promote 
health, and protect from diseases [11]. No comprehensive data on wastewater characteristics 
and amounts discharged are yet available [12]. The effectiveness of the existing urban sewage 
collection and treatment facilities is usually constrained by limited capacity, poor 
maintenance, process malfunction, poor maintenance practices, and lack of experienced or 
properly trained staff [13-14]. Generally, treated wastewater has a long history of applications 
and can serve many purposes for which fresh water is used, primarily in agriculture, and 
additional areas of applications, including industrial, and domestic if undergo suitable 
treatment [15]. To ensure sustainable and successful wastewater reuse applications, the 
following requirements must be fulfilled [16-17]:  
1- The potential public health risk associated with wastewater reuse are evaluated and 
minimized. 
2- The specific water reuse applications meet the water quality objectives. 
 
Presently, raw or partially treated wastewater in many areas in Palestine is discharged to the 
wades where it is used for irrigation purposes. Several studies have shown that the reuse of 
treated effluents for irrigated agriculture is possible in most areas in Palestine. However these 
projects are still on the pilot-scale. In general, Palestinians farmers lack the proper experience 
in using this resource in a safe way [2-6, 12-14, 18-21]. The reuse of treated wastewater must 
be combined with strategies to prevent health risks and environment from pathogens, heavy 
metals, pesticides, personal care products (PCPs), pharmaceuticals and endocrine disrupters. 
Therefore, the Palestinian Water Authority (PWA), the regulator of water sector, has newly 
developed national guidelines based on recommended rules issued by the World Health 
Organization (WHO) to ensure protection of public health and the environment from the 
discharge of untreated or inadequately treated wastewater effluents [22-23].  
 
Development of appropriate and sustainable sewage treatment technologies will help to 
preserve biodiversity, maintain healthy environment and save freshwater supply [7]. Among 
the different treatment systems now available worldwide, the main types of treatment plant are 
used in Palestine: (a) stabilization ponds for small communities [4-5]; (b) trickling filter [4-5]; 
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(c) oxidation ditches [4-5]; and (e) activated sludge or extended aerated activated sludge for a 
large scale community [4-5]. Table 1-1 lists the current status of existing and planned 
wastewater treatment plants in the West Bank [4]. 
 
1.2  Thesis Objectives 
 
The main goal of this research study is to investigate the performance of advanced treatment 
technologies which include integration between activated sludge process with ultra-filtration 
membranes (hollow fiber and spiral wound membranes), activated carbon adsorbent, micelle-
clay filters, and reverse osmosis in terms of removal of aspirin (acetylsalicylic acid) and 
paracetamol (acetaminophen). The wastewater treatment plant located at Al-Quds University 
main campus in Abu-Dies is made from such integrations and samples will be taken from 
different compartments of this plant. Aspirin and paracetamol were chosen since both 
pharmaceuticals are widely consumed and are found to be frequently used medicines in 
Palestine.  
The sub-goals of this research are: 
 Identifying the most popular drugs prescribed in Palestine and preparing a ranking list of 
these drugs.  
 Studying the stability of aspirin and paracetamol in pure water and in the presence of 
wastewater.  
 
1.3 Thesis Outline 
 
This thesis contains five chapters: Chapter 1 contains the introduction, Chapter 2 consists of 
literature review on pharmaceuticals present in wastewater, general information on wastewater 
and the technology used for its treatment, Chapter 3 reviews the materials and the methods 
used, as well as sampling and analysis, Chapter 4, 5 and 6 summarize the results and 
discussion, and Chapter 7 presents the conclusions and recommendations. 
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Table 1-1: Wastewater treatment plants (WWTP) in the West Bank (status and information) [4]. 
 
 Note: *Old and non-functioning sewage treatment plant exists. **Currently rehabilitation of the sewage treatment plant takes place. *** 
Currently rehabilitation of the old sewage treatment plant takes place as a partial solution. (KFW: Kreditanstalt Fuer Wiederaufbau, T.P: 
Treatment Plant). 
Name of 
T.P 
 
Status of T.P 
 
No. of population 
served by T.P 
* 1000 (year) 
Capacity of T.P 
(mcm/year) 
Funding 
Agency 
 
Estimated cost 
for 
construction 
(million US$) 
Technology 
Nablus East Planning phase 240(2021) 9.2 Germany KFW 25 Extended Aeration 
Nablus West Approved 225(2021) 9.0 Germany KFW 25 Extended Aeration 
Salfit Detailed study 24(2025) 2.3 Germany KFW 13 Extended Aeration 
Jenin* 
Rehabilitation is 
needed 
13.5(1997) 0.5 Israel  
Waste stabilization 
ponds 
Al-Bireh Constructed 40(2000) 1.1 Germany KFW 7 Oxidation Ditch 
Tulkarem** No study yet 223(2030) 7.5 Germany KFW 50 
Extended Aeration 
Process 
Abu-Dees Feasibility study 26(2020) 1 Norway  Oxidation Ditch 
Tafuh Feasibility study 16 0.5 UNDP  
Anaerobic Rock 
Filter 
Halhul 
Preliminary 
design 
42(2020) 1.0 Not funded 5.5 Aerated Pond System 
Birzeit area Preliminary Study 28(1994) 1.2 Not funded 4.5 
Imhoff tank and 
trickling Filter 
Hebron Planning stage 695(2020) 25.0 USA 45 Activated Sludge 
Jericho Preliminary Study 26 (2000) 1.2 Not funded   
Biddya Preliminary Study 24 (2000) 1.1 Not funded 10.0  
Ramallah*** Feasibility Study 40 (North) 1.5 Not funded 7.0 Extended Aeration 
  40 (South) 1.5  7.0  
Al-Ram Preliminary Study 86.5(2000) 3.3 Germany KFW 11.0 
Aerobic sludge 
Stabilization+ 
Activated Sludge 
Total  1789 66.3  210  
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Chapter Two 
 
Literature Review 
 
2.1 Introduction 
 
Wastewater contains a mixture of both organic and inorganic constituents. Its composition 
varies from time to time and place to place, basically depending on economic aspects, social 
behavior, type and number of industries located around the collection area, climatic 
conditions, water consumption, and the type and condition of the sewer system [17]. 
 
2.2 Definition of wastewater and its characteristics 
 
Wastewater is defined as the liquid effluents which are discharged from a community after it 
has been contaminated by various ways. It is usually generated from residences, institutions, 
commercial, industrial establishments, and surface and ground water [17]. Wastewater 
consists of  99 percent water by weight and the remaining one percent includes suspended and 
dissolved organic and inorganic substances as well as microorganism [24]. The wastewater 
from residences, institutions, commercial places, and farms are referred to as domestic 
wastewaters [25]. Domestic wastewater, or “sewage”, can also be divided into two groups; 
black-water which is basically wastewater from toilets (urine and etc.) and grey-water refers 
to the household wastewater which has not been contaminated by toilet waste and which 
originates from bathrooms and laundries. Grey-water constitutes the largest flow of 
wastewater [26]. Industrial wastewater generated from industries varies in flow and 
composition depending on the type of industries. A combination of domestic and industrial 
wastewaters often referred to as municipal wastewater [17, 24-27]. 
Wastewater is characterized in terms of its physical, chemical, and biological composition 
[28]. Physical parameters include total solid contents, particle size distribution, turbidity, 
temperature, conductivity, transmittance, density, color, and odor. Total solid contents are 
subdivided into total suspended solids (TSS) and total dissolved solids (TDS). Chemical 
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parameters associated with the organic content of wastewater include biochemical oxygen 
demand (BOD), chemical oxygen demand (COD), total organic carbon (TOC), and total 
oxygen demand (TOD). Inorganic chemical parameters include salinity, hardness, pH, acidity 
and alkalinity, as well as concentrations of ionized metals such as iron and manganese, and 
anionic entities such as chlorides, sulfates, sulfides, nitrates, and phosphates. Bacteriological 
parameters include coliforms, fecal coliforms, specific pathogens, and viruses [17, 28]. 
 
2.3  Overview of wastewater treatment 
 
Wastewater treatment is the process of removing varying amounts of contaminants from 
wastewater, depending on the level and type of treatment they provide. Its objective is to 
optimize the benefits of wastewater as a resource of both water and nutrients, and to ensure 
protection of public health and the environment from the discharge of untreated or 
inadequately treated wastewater effluents [29]. Also, in wastewater reclamation and reuse, 
water quality requirements may call for reduction in suspended solids, total dissolved solids, 
pathogenic microorganism (i.e. bacteria, protozoan, and viruses), as well as selected 
constituents such as nitrates, chlorides, and natural and synthetic organic compounds [17]. 
 
2.3.1 Wastewater treatment plant process  
 
Wastewater treatment process includes physical, chemical, and biological units to remove 
physical, chemical, and biological contaminants. Typically, wastewater treatment process 
(Figure 2-1) can be broken down into four basic steps: preliminary, primary, secondary, and 
tertiary. These treatments are to achieve different levels of contaminant removal. Primary and 
secondary unit operations and processes are called conventional wastewater treatment. After 
conventional wastewater treatment, tertiary (advanced treatment) treatment improves the 
quality of secondary wastewater and produces an effluent that can be used as a substitute of 
freshwater sources for household and industrial needs [17, 28, 30-31]. 
The initial steps are collectively known as preliminary treatment, in which oils, grease, fats 
and gross objects such as large objects, rags, and grit are removed through combination of 
screening and settling by gravity [17, 30]. Primary treatment involves partial removal of 
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suspended solids and organic matter found in wastewater by means of physical operations 
such as screening and sedimentation prior to biological treatment. Primary treatment acts as a 
precursor for secondary treatment. The secondary treatment is designed for removal of 
biodegradable dissolved and colloidal organics and suspended solids that have escaped the 
primary treatment by utilizing biological treatment processes. In secondary treatment unit, 
three types of technologies can be applied to break down organic material with agitation and 
aeration. These are: activated sludge process, trickling filters, and lagoon systems [17, 30]. 
The activated sludge process use a variety of mechanisms to utilize dissolved oxygen to 
promote the growth of a biological floc that substantially breaks down and removes organic 
material, then allows these solid flocs to settle out. Bacteria-containing “activated sludge” is 
continually re-circulated back to the aeration basin to increase the rate of organic 
decomposition [27, 32]. After primary and secondary treatment, several physical–chemical 
processes have been investigated as tertiary treatment of secondary effluents, including 
ozonation, photo-catalytic degradation of recalcitrant compounds (UV/TiO2) [33], and 
adsorption [28, 31-32]. Tertiary treatment is often performed by a sequence of 
coagulation/flocculation, membrane filtration, and disinfection [31]. The effluents obtained 
from the combination of tertiary treatment processes are generally of good quality and can be 
used in different sectors: industry, agriculture, and urban consumption. This treated 
wastewater contains low concentrations of organic matter, inorganic ions (nitrates, sulfates 
and phosphates), and pathogenic microorganism which meets the requirements for the reuse 
criteria for wastewater so that it minimizes its potential negative impact on public health and 
to reduce environmental damage [31, 34]. Any settled solids (sludge) from any treatment 
process are given further treatment and undergone several options for disposal [17, 24]. 
Application of sewage sludge to agricultural land may be beneficial because it can improve 
and maintain productive soils which may enhance plant growth. In addition, the use of sludge 
as a fertilizer would decrease the amounts of chemical fertilizers needed in agriculture [17, 24, 
35].  
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2.3.2 Membrane Filtration  
 
Membranes filtration are frequently used for tertiary treatment of wastewater before discharge 
to surface water, recover materials in industry before they enter waste streams, and to treat 
waters for potable use [36]. Nowadays, membrane processes can play a key role in reducing 
water scarcity mainly in areas with scarce water supplies. These membranes are also 
increasingly being considered as essential additions to conventional water and wastewater 
treatment methods in anticipation of future demands for high standards and reduced 
environmental impact [31-40]. 
Membranes are semi-permeable barriers that are used to separate and remove constituents 
from a fluid stream ranging from large visible particles to molecular and ionic chemical 
species including bacteria, viruses, and other pathogenic microorganisms [17, 36]. In 
membrane separation process, the feed water is separated into a stream that can pass through 
the membrane, i.e., permeate and a fraction of feed that cannot pass through the membrane, 
i.e., the concentrate (Brine). Membrane process can be classified in terms of the size of the 
membrane pores or molecular weight cutoff (MWCO) which specifies the maximum 
molecular weight of a solute to be rejected, the separation mechanism, the nature of the 
driving force, the chemical structure and composition of membranes, and the geometry of 
construction [36]. A schematic representation of a membrane separation process is given in 
Figure 2-2.  
 
2.3.2.1 Types of membranes  
 
Most commercial membrane modules are manufactured in four configurations as spiral 
wound, hollow fibers, plate-and-frame, and tubular [41-42]. The principal types of membrane 
modules used for water and wastewater treatment are hollow fiber and spiral wound [17, 43]. 
In a hollow fiber element (Figure 2-3(a)), fibers made of porous polymer material are bundled 
together and sealed in a cylindrical pressure vessel. The feed flows into the module, the 
permeate flows into or out of the hollow fibers and is collected, while the retentate exits the 
module for further treatment [42]. 
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As shown in (Figure 2-3 (b)), spiral wound elements consist of two flat membrane sheets 
separated by a thin, mesh-like porous support or spacer and are sealed on three sides like an 
envelope. The fourth side is fixed onto a perforated plastic center tube that collects the product 
water (permeate). The membranes are rolled up around the tube in the form of a spiral. Feed 
water is pumped through the layers and the product water (permeate) passes through the 
membrane into the permeate spacer and then is collected in the central perforated collection 
tube. The retentate exits from the feed spacers at the opposite end of the spiral sheet. Hollow 
fiber and spiral elements are used for microfiltration (MF), ultrafiltration (UF), and reverse 
osmosis (RO) [42].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1: A schematic representation of a wastewater treatment classification.  
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Figure 2-2: A schematic of operation of a membrane process. 
 
 
Figure 2-3: Hollow fiber (a) and spiral wound (b) modules [38]. 
 
The driving force for membrane process can be external pressure, electrical potential gradient, 
concentration gradient, or other driving forces [17, 36]. The most commonly used membrane 
systems in water and wastewater treatment are pressure-driven membranes, therefore, most of 
the discussion in this section focuses on them. Pressure-driven membrane processes are 
typically classified into four common categories depending on their pore size: microfiltration 
(MF), ultrafiltration (UF), nanofiltration (NF), and reverse osmosis (RO) [36, 38, 41-43]. The 
various pressures-driven membrane processes and their separation characteristics are shown in 
Table 2-1. 
 
  
Membrane Filtration 
Unit 
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Table 2-1: Comparison of pressure-driven membrane systems 
 
Parameters 
Membrane system 
Low-pressure membranes High-pressure membranes 
MF UF NF RO 
Product particle 
size (µm) 
0.08 to 2.0 0.005 to 0.2 0.001 to 0.01 0.0001 to 0.001 
Retained 
compounds 
Very small 
suspended 
particles, some 
colloids, most 
bacteria 
Organic 
compounds > 
1000 Da, 
pyrogens, 
viruses, bacteria, 
colloids 
Organic 
compounds  > 
200 Da, some 
dissolved solids 
(i.e. multivalent 
ions) 
Ions, Organic 
compounds >100 
Da MW 
Operating 
pressure, psi 
1 to 15 30 to 100 80 to 125 ≥ 1,000 
 
2.3.2.1.1 Microfiltration (MF) and Ultrafiltration (UF)  
 
Low-pressure driven membranes (LPMs) include MF and UF which are typically operated 
under trans-membrane pressures of 100 pound per square inch (psi) or less (700 kPa). They 
are characterized by their ability to reduce turbidity, and remove suspended or colloidal 
particles via sieving mechanism. In wastewater reclamation, MF and UF are considered as a 
pretreatment step for RO and NF, so that fouling potential of the less permeable membranes is 
minimized and can be realized. MF have a pore size ranging between approximately 0.08-
2.0µm, although there are exceptions, as MF with pores sizes of up to 10µm are available, 
with MWCO greater than of approximately 100 kD (D; g mol
-1
). While UF pore size generally 
ranges from 0.005-0.2µm, with MWCO of approximately 10 to 100 kD. UF membranes are 
designed to remove dissolved macromolecules solutes from feed water, such as colloids, 
proteins, and carbohydrates. Therefore, UF offers higher removals efficiency than the MF; 
however, UF membranes do not remove ultra small substances such as sugar and salts [17, 36, 
37, 41].  
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2.3.2.1.2 Nanofiltration (NF) and Reverse Osmosis (RO) 
 
High-pressure driven membranes (HPMs) generally refer to NF and RO which are required 
for the removal of ultra-small dissolved contaminants via a softening or desalination 
mechanisms. NF also called “membrane softening” is designed for the removal of selected 
dissolved constituents from wastewater such as multivalent ions (i.e. calcium and magnesium) 
responsible for water hardness [17]. RO is used primarily for desalination, in which water is 
transferred through a dense membrane to retain salts and low molecular weight solutes [17, 
36, 41]. Therefore, pushing water through membrane pores requires a higher operating 
pressure than MF and UF. The required operating pressure can range from less than 150 psi 
(1000 kPa) for some NF applications to more than 1,000 psi (7000 kPa) for RO. 
Commercially available HPMs employed in wastewater reclamation usually have small pore 
sizes ranging between approximately 0.01-0.001μm and 0.001-0.0001µm for NF and for RO 
membranes, respectively. With this ultra small pore size, the attainable range of MWCO 
levels is less than 100D for RO membranes and between 200 and 1,000D for NF membranes 
[16, 39].  
 
Reverse osmosis, Figure 2-4, is the reversal of the natural osmotic process, accomplished by 
applying pressure in excess of the osmotic pressure to the more concentrated solution. This 
pressure forces the water through the membrane against the natural osmotic gradient, thereby 
increasingly concentrating the water on one side (i.e., the feed) of the membrane and 
increasing the volume of water with a lower concentration of dissolved solids on the opposite 
side (i.e., the filtrate or permeate) [17, 42]. 
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Figure 2-4: The principle of reverse osmosis process. 
 
2.4  Occurrence of Pharmaceuticals in wastewater 
 
In recent years, the occurrence of pharmaceuticals and personal care products (PPCPs) and 
their metabolites in the aquatic environment has been recognized as being an important part of 
the chemicals that are present in low concentrations in the environment. A variety of 
pharmaceuticals have been detected in many environmental samples worldwide. Their 
occurrence has been reported in sewage treatment plant effluents, surface water, seawater, 
groundwater, soil, sediment and fish [44-51]. 
 
2.4.1 Pharmaceuticals and personal care products (PPCPs) Background 
 
Pharmaceutically active compounds (sometimes called active pharmaceutical ingredients or 
APIs) cover a wide-range of compounds with substantial variability in structures, function, 
behavior and activity, in which they are developed and designed to interfere with biological 
systems, and have an important role in diagnosis, treatment, prevention the disease, health 
conditions, or functions of human body and/or animals [44, 51]. These substances include 
both inorganic and organic compounds, although most of the modern pharmaceuticals are 
small organic compounds with a molecular weight below 500 Daltons. These chemicals are 
moderately water soluble as well as lipophilic to be bioavailable and biologically active [52]. 
Pharmaceuticals are produced and used in increasingly large volumes every year [53]. 
Examples of pharmaceutical compounds include antipyretics, analgesics, blood lipid 
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regulators, antibiotics, antidepressants, chemotherapy agents, and contraceptive drugs. 
Personal care products (PCPs) are defined as chemicals marketed for direct use by the 
consumer in order to alter odor, appearance, and touch without displaying significant 
biochemical activity (except over-the-counter, OTC, medications) and having intended end 
uses primarily on the human body (products not intended for ingestion with exception of food 
supplements) [44]. They include cosmetics, bath additives, shampoo, skin care products, oral 
hygiene products, hair sprays, sun screens, hair dyes, deodorants, perfumes, soaps, fragrances, 
veterinary drugs, insect repellents and lotions. The expectations of the amounts of these 
products will continue to increase due to the increase in the standards of living as reflected by 
the improvement in the health care system and longer life expectancy.  
The term endocrine disrupters (EDs) refer, in general, to the synthetic chemicals and natural 
compounds that may affect the endocrine system (the communication system of glands, 
hormones, and cellular receptors) that control the body’s internal functions [54]. Endocrine 
disrupters has recently attracted much attention since many of these disrupters cause negative 
reproductive and developmental health effects for the human or animals and its offspring [55-
56]. 
 
2.4.2 Analytical methods 
 
Although pharmaceuticals and endocrine disrupters have been detected in a wide variety of 
environmental samples including wastewater effluents, rivers, lakes, surface waters, 
groundwater and drinking water for decades, researchers have recently begun to quantify their 
levels in the environment due to the development of new analytical technologies that result in 
the detection of minute traces of pharmaceuticals and other organic chemicals [57]. These 
analytical methods have become sufficiently sensitive to identify and quantify their presence 
in wastewater treatment plant (WWTP) effluents, surface waters, drinking water, and ground 
water. Investigations carried out in many countries have detected more than 80 
pharmaceuticals, their metabolites, and pharmaceuticals care products in aquatic environment 
at concentrations in the range of mg\l  (ppm) to ng\l (ppt) levels [58-59]. Reported compounds 
include wide range of classes of pharmaceuticals: analgesics, anti-inflammatory compounds, 
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beta-blockers, lipid regulators, antiepileptics, antibiotics, X-ray media contrast agents, 
cytostatic agents, and contraceptives [59].  
 
Because PPCPs and EDs represent structurally diverse classes of compounds, the different 
analytical methods have been used and applied for identification and quantification of these 
chemicals in water samples. The measurement of these compounds in water most commonly 
consist of an extraction of the chemicals from water, concentration of the resulting extract, 
and chromatographic separation by gas or liquid chromatography using high sensitivity 
detector. Due to the complexity of wastewater samples, the extraction techniques such as 
liquid-liquid and steam distillation have been used to extract these compounds from 
wastewater and water, however solid phase extraction (SPE) is the most common technique 
employed for sample enrichment. Variations of SPE include solid phase microextraction 
(SPME) and various on-line and automated SPE techniques [60-61]. 
 
2.4.3 Sources in the environment 
 
After the administration, drug molecules are absorbed, distributed, metabolized, and finally 
excreted from the body. To be used safely most of the pharmaceuticals are designed in a way 
to undergo metabolism (enzymatic transformations) in organs such as liver, intestine, kidney, 
and lungs after they have achieved desired pharmacological effects. In most cases, 
pharmaceuticals are excreted as one or several metabolites. These metabolites are typically the 
result of either phase 1 or phase 2 metabolic reactions [62]. They excreted to the sewer system 
via urine and feces and reach WWTPs where they do not undergo further degradation to a 
satisfactory degree. Hence, WWTPs play a key role in the introduction of pharmaceuticals 
into the environment. Veterinary and human pharmaceuticals and their metabolites enter the 
environment by two main pathways. The first is via the effluents from wastewater treatment 
plants (WWTPs) (Figure 2-5). The second route by which pharmaceuticals can enter the 
environment is by the disposal of unwanted medicines and/or medications that have expired 
and ended in the sink/toilet or in household waste which subsequently are taken to landfill 
sites (Figure 2-5) [53]. Entry into the environment by this route is dependent on the habits of 
the society and level of education. 
19 
 
2.4.4 Physicochemical properties 
 
The fate of organic substance, once released in the environment is determined by their 
physicochemical and biodegradability properties, water solubility, hydrophobicity and 
tendency to volatilize [63]. These properties will influence whether compounds will remain in 
the aqueous phase or adsorb to sewage sludge. The tendency for organic compounds to 
accumulate in sludge solids can be assessed using octanol-water partition coefficient Kow (or 
log P). Table 2-2 shows the adsorption potential of organic substances depending on their Kow 
values [64]. 
Table 2-2: Adsorption potential dependence on log Kow. 
Log Kow ≤ 2.5 Low sorption potential 
2.5 ˂ Log Kow ˂ 4.0 Medium sorption potential 
Log Kow ≥ 4.0 High sorption potential 
 
2.4.5  Environmental occurrence, fate, and removal of PPCPs   
 
Many scientific articles clearly document the release of PPCPs into the environment, and their 
presence in ground water, surface waters, and wastewater treatment plant effluents. 
Furthermore, the occurrence, fate and the concentration of these pharmaceuticals in the 
environments were also documented [44-51, 53, 55, 56]. Currently, intensive research is 
underway to investigate the effect of human and animal’s medications on the environments. A 
brief summary of relevant studies in this field is outlined in the following paragraph.  
 
A very comprehensive review is given by Daughton and Ternes about the occurrence, fate and 
causes of PPCPs in aquatic environment. Their study revealed that the most frequently PPCPs 
found in environmental sample are acetaminophen, acetylsalicylic acid, betaxol, bezafibrate, 
biphenylol, bisoprolol, carazolol, carbamazepine, and chlorophene [44]. Studies on tertiary 
wastewater treatment plant effluents and nearby wells and creeks in the Sequim-Dungeness 
area of northwest Washington detected 16 compounds in wastewater samples. These 
compounds are acetaminophen, caffeine, carbamazebine, cimetidine, codeine, cotinine 
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(metabolite of nicotine), diltiazem, hydrocodone, ketoprofen, metformin, nicotine, 
paraxanthine, salbutamol, sulfamethoxazole, trimethoprim, and estrone [58]. Kolpin et al. 
(2002) provided the first U.S nationwide reconnaissance of the occurrence of pharmaceuticals, 
hormones, and other organic wastewater contaminants (OWCs) in streams. The U.S 
Geological Survey (USGS) found 80% of the sampled streams contained organic 
contaminants, and the compounds most frequently detected were pharmaceuticals. The most 
frequently detected compounds are steroids (including cholesterol), nonprescription drugs 
(such as caffeine, nicotine metabolites, and pain relievers), triclosan (antiseptic), and DEET 
(N,N-Diethyl-meta-toluamide is the most common active ingredient in many insect repellents) 
[49].  
Other Studies indicate that PPCPs are already harming wildlife at levels found in water and 
have shown a potential negative effects on fish, plants, algae, bacteria, earthworm, and dung 
invertebrates [57]. Example of negative impacts of EDs to aquatic organism is the 
contribution of synthetic estrogens, also known endocrine disruptors, to the feminization of 
male fish in waters receiving treated wastewater effluents [56, 65]. On the other hand, it was 
proven that drinking water contaminated by wastewater is a potential source of exposure to 
mammary carcinogens and endocrine disrupting compounds from commercial products, 
natural as well as pharmaceutical hormones. These contaminants are hypothesized to increase 
breast cancer risk [66]. Also, it has been reported that the effect of the pharmaceuticals and 
EDs on human body are: reduction of the amount of sperm, increase of the incidence of  
testicle and prostate cancers; and increased endometriosis [67]. 
 
Although concentrations of many pharmaceuticals residues in potable drinking water are so 
low that they do not pose high risks to human beings [68], the main concern is the chronic 
and/or synergistic effects of the “cocktail” of pharmaceuticals that humans have released to 
water-body. Some published reports raised issues related to the possible development of 
antibiotic-resistant bacteria upon exposure to untreated hospital and domestic sewage effluent 
[69], the genotoxic effects of some drugs [70], and endocrine disruption by therapeutically 
administered synthetic and natural hormones [48, 70-72]. 
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Effluents from wastewater treatment plants can be considered as one of the most important 
sources of pharmaceuticals in the environment [44, 73-74]; therefore, the need for wastewater 
treatment technologies is required and plays an important role in removing pharmaceuticals 
and other contaminants [45]. Effective treatment technologies are also needed in order to 
ensure a safe use for reclaimed wastewater because Palestine suffers from an increase demand 
for water due to the rising population with very limited resources for water supply [1-3].  
 
The methods of treatment used for the removal of pharmaceuticals from wastewater are the 
following [74-75]: (1) biodegradation: biological degradation (aerobic/anaerobic by micro-
organisms) of drug substances leading to a reduction of the parent compounds and/or their 
metabolites during wastewater treatment. (2) Deconjugation: conjugates of organic 
compounds such as steroid hormones have been shown to be readily deconjugated in domestic 
wastewater and within sewage treatment plants (STPs) due to the large amounts of β-
glucuridase enzyme present (produced by the fecal bacterium Eacherichia coli). It seems 
probable that gluconoride and sulfate conjugates of drug compounds will be degraded by the 
same process. The effect will be to increase the excreted contribution of the active drugs to 
sewage and effluents. (3) Partitioning: partitioning between the aqueous and organic biomass 
phases is a key component in determining the ultimate concentrations of organic pollutants. 
Compounds with high log P (lipophylic molecules) values are known to sorb to sludge, while 
substances with lower values are more likely to stay in the aquatic phase, depending on the 
individual compound, and substances sorbing to solids may also be remobilized if they are not 
strongly bound. (4) Removal during sludge treatment: drugs may also be degraded by abiotic 
process (hydrolysis) during sewage treatment processes. Many pharmaceuticals are not 
thermally stable and so might be expected to break down during processes such as composting 
due to heat (as well as chemical and biodegradation). (5) Photodegradation: several 
pharmaceutical compounds have been shown to degrade due to the action of sunlight. The 
most extensively studied of these compounds is the analgesic/anti-inflammatory drug 
diclofenac, which has been shown to degrade in the aquatic environment due to ultraviolet 
(UV) light. 
Because of an incomplete elimination in wastewater treatment plants, residues of many toxic 
organic compounds, including pharmaceutical products, are also found in surface waters. 
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Advanced treatments have to be considered to overcome this problem. Several processes have 
been studied to remove pharmaceuticals from water. Researchers reported a significant 
efficiency of nanofiltration and reverse osmosis membrane filtration [74], advanced oxidation 
processes [72] and activated carbon adsorption [74-75]. 
 
In Palestine, this study is the first to report on the removal of pharmaceuticals by ultrafiltration 
membranes (hollow fiber and spiral wound), their adsorption by activated carbon and clay-
micelle filters, and removal by reverse osmosis technology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5: Pathways and fate of PPCPs from domestic households to the environment. 
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Chapter Three 
 
Experimental 
 
This chapter is divided into four parts. The first one is concerned with the identification of the 
most popular drugs prescribed in Palestine. Part two describes the instruments, chemicals, and 
reagents that this study utilizes. The last two parts deal with specific preparation and analysis 
of aspirin and paracetamol.  
 
3.1 Part One  
 
3.1.1 Identification of the most popular drugs in Palestine 
 
In the first stage of this study, we have evaluated the most popular drugs in Palestine by 
conducting a search on 7000 members of Kubat Holeim Klalit using “Omri” program. This 
program stores the medication files for all population in Israel and East Jerusalem [76]. 
 
3.2 Part Two  
  
3.2.1 Instrumentation 
 
3.2.1.1 High Pressure Liquid Chromatography  
 
High Pressure Liquid Chromatography (HPLC-PDA) system consists of an alliance 2695 
HPLC from (Waters: Israel), and a waters Micromass® Masslynx ™ detector with Photo 
diode array (PDA) (Waters 2996: Israel). Data acquisition and control were carried out using 
Empower ™ software (Waters: Israel). Analytes were separated on a 4.6 mm x150 mm C18 
XBridge ® column (5 µm particle size) used in conjunction with a 4.6mmx20 µm XBridge ™ 
C18 guard column. Microfilter was used with 0.45µm (Acrodisc® GHP, Waters).  
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3.2.1.2 UV-Spectrophotometer  
 
The concentrations of samples of the adsorption experiments were determined 
spectrophotometrically (UV-spectrophotometer, Model: UV-1601, Shimadzu, Japan) by 
monitoring the absorbance at λmax  for each drug. 
 
3.2.1.3 pH meter  
 
pH values were recorded on pH meter model HM-30G: TOA electronics ™ was used in this 
study to measure the pH value for each sample.  
 
3.2.1.4 Centrifuge and Shaker 
 
Labofuge
®
200 Centrifuge was used, 230 V 50/60 Hz. CAT. No.  284811. Made in Germany. 
Some of pharmaceuticals solutions were shaken with an electronic shaker (Bigbill shaker, 
Model No.: M49120-26, 220-240 V 50\60 Hz.) at 250 rpm.   
   
3.2.1.5 Description of Wastewater Treatment Plant (WWTP) 
 
The wastewater treatment plant (WWTP) at Al-Quds University collects a mixture of black, 
gray, and storm water. The treatment plant consists of: a primary treatment (two stage primary 
settling basin), and a secondary (activated sludge with a hydraulic retention time of 16-20 
hours, coagulation and chlorination) treatment. Then, the secondary effluent is introduced to 
the sand filter before entering the ultrafiltration membrane (Hollow fiber and Spiral wound). 
After the ultrafiltration process, the effluent is subjected to activated carbon column followed 
by a reverse osmosis (advanced treatment). Then, a blend of all effluents is used for irrigation. 
The ultra filtration process is made of two small scale membrane treatment plants with a 
capacity of 12 m
3
 /day. The first UF unit is equipped with 2 x 4 inch pressure vessels with 
pressure resistance up to 150 psi. Each vessel holds two separation membranes (spiral wound 
with 20 kD cutoffs which is equivalent to 0.01 micron separation rate). The designed permeate 
capacity of the system is 0.5-0.8 m
3
/h. This membrane can remove bacteria, suspended solids, 
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turbidity agents, oil, and emulsions. The second unit is equipped with two pressure vessels 
made from Vendor (AST technologies, model number 8000 WW 1000-2M) that houses the 
hollow fiber membranes with 100 kD cutoff (Vendor, AST technologies, Model no. 8000- 
WWOUT-IN-8080). The two units are designed to deliver 1.5m
3
/h. The reverse osmosis (RO) 
membranes are made from thin film polyamide which consists of 1 x 4 inch pressure vessel 
made from composite material with pressure resistance up to 400 psi. The vessel holds two 4 
inches special separation membranes (manufactured in thin film polyamide with pH range 1-
11 models BW30-4040 by DOW Film Tec.). Membrane anti-scalent (Product NCS-106-FG, 
made of phosphate in water with active ingredient of phosphonic acid disodium salt) are 
continuously dosed to the RO feed at concentration of 4 ppm  in order to prevent deposition of 
divalent ions. The system is designed to remove major ions and heavy metals. The designed 
RO permeate capacity of the system is 0.45- 0.5 m
3
/h.  
 
3.2.2 Chemicals and Reagents 
 
Pure standards (>99 %) of aspirin, salicylic acid, paracetamol and p-aminophenol are 
commercially available (Sigma–Aldrich). Methanol and water are both HPLC grade and 
purchased from Sigma Aldrich. Magnesium sulfate and Charcoal were purchased from Sigma-
Aldrich. Octadecyltriethylammonium clay-micelle complex (ODTMA) was obtained as a gift 
[77] from Professor Nir at The Hebrew University. High purity diethyl ether (>99%) was 
purchased from Biolab, Hydrochloric acid (37%), and orthophosphoric acid (OPA) were 
obtained from Riedel-De Haen. Tap water was filtered using 0.22μm filter.  
 
3.3 Part Three   
 
3.3.1 Methods (Aspirin and Salicylic acid)   
 
3.3.1.1 Sample and standards preparation 
(a) Stock solution: Stock solution was prepared by dissolving aspirin and salicylic acid 
standards in a mixture of methanol: water that adjusted to pH 3.45 in a ratio (45:55 v\v) to a 
concentration of 200 ppm for the use in (b).   
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(b) Calibration curves: A 500 ml stock solution of 1:1 mixture of aspirin and salicylic acid 
with a final concentration of 200 ppm was prepared in the same manner as for (a). The 
following diluted solutions were prepared from the stock solution: 1, 2, 3, 5, 10, 20, 40, 60, 
100, 120, 140, and 160 ppm. Then, each diluted solution was extracted three times with ether. 
The ether extracts were combined, dried with anhydrous magnesium sulfate (MgSO4), filtered 
and evaporated. For HPLC-PDA analysis, the dried residue after evaporated ether was 
dissolved with a mixture of methanol: water (adjusted to pH 3.45) (45:55 v\v) and was 
injected to the HPLC apparatus. 
 
3.3.1.2 Kinetic studies on the stability of aspirin in pure water and wastewater 
 
(a) Kinetic study on the stability of aspirin in pure water:  For the hydrolysis reaction of 
aspirin in pure water, a 500 ppm solution was used. The reaction progress was followed by 
monitoring the disappearance of aspirin and the appearance of salicylic acid with time at (25
o 
C) using the HPLC method. 
(b) Kinetic study on the stability of aspirin in presence of wastewater: The same 
procedure as described in (a) was used for the hydrolysis of aspirin in the presence of 
wastewater. However, in this case water was replaced with a suspended wastewater in plain 
water at 25
o
 C. 
 
Samples at specific time intervals were taken. Then, the sample aqueous layer was extracted 
three times with ether. The ether extracts were combined, dried with anhydrous MgSO4, 
filtered and evaporated. For HPLC-PDA analysis, the dried residue was dissolved in a mixture 
of methanol: water (adjusted to pH 3.45) (45:55 v\v) and was injected to the HPLC apparatus. 
 
3.3.1.3 Liquid-liquid extraction  
 
Liquid-liquid extraction procedure was applied to the diluted solutions (samples of calibration 
curve) and wastewater samples using diethyl ether solvent. Each 10mL of sample was 
extracted three times with ether. The ether extracts were combined, dried with anhydrous 
MgSO4, filtered and evaporated. For HPLC-PDA analysis, the dried residue was dissolved in 
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10mL mixture of methanol: water (adjusted to pH 3.45) (45:55 v\v) and was injected to the 
HPLC apparatus. 
 
3.3.1.4 Salicylic acid wastewater spiking and sampling 
 
Sample of 60 g of salicylic acid was dissolved in a minimum amount of methanol and was 
poured immediately into the wastewater tank. Then, eight wastewater samples were collected 
from different locations of wastewater treatment plant (WWTP) (Figure 3-1).  Samples were 
kept on ice during transportation to the laboratory. Once received, conventional wastewater 
parameters including total dissolved solids (TDS), temperature, and pH were measured then 
the samples were filtered and adjusted to pH (< 2) by the addition of few drops of 
concentrated hydrochloric acid (HCl), and then stored at 4 ºC until extraction. (See diagram in 
Figure 3-2). 
 
3.3.1.5 Chromatographic conditions for the separation of aspirin and salicylic acid 
 
All samples were analyzed using HPLC-PDA. The optimum HPLC conditions that was used 
for the analysis of salicylic acid are: a C-18 as the column, a mixture of water: methanol 
(water pH adjusted to 3.4 using dilute o-phosphoric acid) (55:45 v/v) as a mobile phase, a 
flow rate of 2 ml/ minute and a UV detection at a wavelength of 230 nm. 
 
3.3.1.6 Adsorption studies of salicylic acid onto micelle-clay complex and charcoal  
 
3.3.1.6.1 Sample and Standards preparation 
(a) Stock solution: Stock solution was prepared by dissolving salicylic acid standard in 
distilled water of 500 ppm concentration, to be used in (b).   
 
(b) Calibration curves: A 500 ml stock solution of salicylic acid with a final concentration of 
500 ppm that was prepared in (a) used to prepare the following diluted solutions: 1 ppm, 2 
ppm, 4 ppm, 6 ppm, 8 ppm, 10 ppm, 20 ppm,40 ppm, 60 ppm, 80 ppm, and 100 ppm. Then, 
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absorption of each solution was determined using UV-spectrophotometer at wavelength (λ 
max) 296.6 nm. 
 
3.3.1.6.2 Adsorption experiment 
 
The salicylic acid was used as adsorbate. Stock solution of salicylic acid was prepared using 
filtered tap water. All working solutions were prepared by diluting the stock solution with 
filtered tap water. The amount of adsorbent (powdered activated carbon and clay-micelle 
complex) was 0.5 g in 100 mL of salicylic acid solutions with the concentration in the range 
of 100 to 400 ppm. The salicylic acid solutions were shaken at 250 rpm until the solutions 
have reached their equilibrium for 3 hours. Then, the samples were centrifuged and filtered. 
The equilibrium concentrations of unadsorbed salicylic acid in the supernatant solutions were 
measured by UV-visible spectrophotometer. Wavelength of 296.6 nm was used to analyze the 
concentration of salicylic acid. The mass of pharmaceutical (salicylic acid) sorbed, Qe, was 
determined by mass balance as shown below: 
 
     
     
 
        
Where Qe is the mass of pharmaceutical (salicylic acid) sorbed (mg g
-1
); Ci is the initial 
concentration (mg L
-1
); Ce is the equilibrium concentration (mg L
-1
); M is the mass of 
adsorbent (g); and Vt  is the total volume of liquid in sample (L). 
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Figure 3-1:  Flow diagram showing the process of wastewater treatment plant which consists of HF-UF filters (hollow fiber) and 
SW-UF (spiral wound), activated carbon and RO filters. The sampling locations in the plant are indicated by red printed Arabic 
numbers.
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Figure 3-2: Schematic representation for the analysis process of salicylic acid, paracetamol, 
and p-aminophenol. (Note: paracetamol and p-aminophenol followed all steps without the 
acidification step). 
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3.4 Part Four  
 
3.4.1 Methods  (Paracetamol and p-aminophenol)   
 
3.4.1.1 Sample and standards preparation 
(a) Stock solution: Stock solution was prepared by dissolving paracetamol standard and p-
aminophenol standard in acetonitrile and water that adjusted to pH 3.45 in a ratio (10:90) to a 
concentration 200 ppm to be used in (b).   
 
(b) Calibration curves: A 500 ml stock solution of 1:1 mixture of paracetamol and p-
aminophenol with a final concentration of 100 ppm was prepared in the same manner as for 
(a). The diluted solutions that were prepared from the stock solution are: 3 ppm, 5 ppm, 10 
ppm, 20 ppm, 40 ppm, 60 ppm, 80 ppm and 100 ppm. Then, each diluted solution was 
extracted three times with ether. The ether extracts were combined, dried with anhydrous 
magnesium sulfate (MgSO4), filtered and evaporated. For HPLC-PDA analysis, the dried 
residue after evaporated ether was dissolved with a mixture of water: acetonitrile (water 
adjusted to pH 3.45 using dilute o-phosphoric acid) in a ratio (90:10 v\v) and was injected to 
the HPLC apparatus. 
 
3.4.1.2 Kinetic studies on the stability of paracetamol in pure water and wastewater 
 
(a) Kinetic study on the stability of paracetamol in pure water: For the hydrolysis reaction 
of paracetamol in pure water, a 200 ppm solution was used. The reaction progress was 
followed by HPLC method. 
(b) Kinetic study on the stability of paracetamol in the presence of sludge: The same 
procedure as described in (a) was used for the hydrolysis of paracetamol in the presence of 
wastewater. However, in this case water was replaced with a suspended sludge in plain water.  
 
Samples at specific time intervals were taken. Then, the sample aqueous layer was extracted 
three times with ether. The ether extracts were combined, dried with anhydrous MgSO4, 
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filtered and evaporated. For HPLC-PDA analysis, the dried residue was dissolved in a mixture 
of acetonitrile: water (adjusted to pH 3.45) (10:90 v\v) and was injected to the HPLC 
apparatus. 
 
3.4.1.3 Liquid-Liquid extraction  
 
Liquid-liquid extraction procedure was applied to the diluted solutions (samples of calibration 
curve) and wastewater samples using diethyl ether solvent. Then, 10 mL of each sample was 
extracted three times with ether. The ether extracts were combined dried with anhydrous 
MgSO4 filtered and evaporated. For HPLC-PDA analysis, the dried residue was dissolved 
with 10 mL of a mixture of acetonitrile: water (adjusted to pH 3.45) (10:90 v\v) and was 
injected to the HPLC apparatus. 
 
3.4.1.4 Paracetamol and p-aminophenol wastewater spiking and sampling 
 
A sample of a mixture of 25 g of paracetamol and 25 g of p-aminophenol were dissolved in 
minimum amount of methanol and were poured immediately into the wastewater tank. Then, 
eight wastewater samples were collected from different locations of wastewater treatment 
plant (WWTP) (Figure 3-1). Samples were kept on ice during transport to the laboratory. 
Once received, conventional wastewater parameters including total dissolved solids (TDS), 
temperature, and pH were measured, the samples were filtered, and then stored at 4 ºC until 
extraction (See diagram in Figure 3-2). 
 
3.4.1.5 Chromatographic conditions for the separation of paracetamol and p-
aminophenol  
 
The optimum HPLC conditions that was used for the separation of paracetamol and p-
aminophenol are: C-18 as the separation column, a mixture of water: acetonitrile (water pH 
adjusted to 3.45 using dilute o-phosphoric acid) (90:10 v/v) as a mobile phase,  flow rate of 
1.0 ml/ minute and a UV detection at a wavelength of 247 nm.  
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3.4.1.6 Adsorption studies of parcetamol and p-aminophenol onto micelle-clay complex 
and charcoal 
 
3.4.1.6.1 Sample and Standards preparation  
(a) Stock solution: Each stock solution of paracetamol and p-aminophenol standard was 
prepared in a separated two volumetric flask by dissolving them in distilled water to a 
concentration 500 ppm that used in (b).   
 
(b) Calibration curves: Each 500 ml stock solution of paracetamol and p-aminophenol with a 
final concentration of 500 ppm was prepared in (a) used to prepare the following diluted 
solutions: 1 ppm, 2 ppm, 4 ppm, 6 ppm, 8 ppm, and 10 ppm. Then, the absorption of each 
solution of paracetamol and p-aminophenol was determined using UV-spectrophotometer at 
wavelength (λ max)  243 nm and 195 nm, respectively. 
 
3.4.1.6.2 Adsorption experiment 
 
Paracetamol and p-aminophenol were used as adsorbate. Each stock solution of each one of 
adsorbate was prepared using filtered tap water. All working solutions were prepared by 
diluting the stock solution with filtered water. The concentrations of paracetamol and p-
aminophenol were determined spectrophotometrically by monitoring the absorbance at 243 
nm and 195 nm, respectively, where maximum absorbance was observed. All solutions were 
shaken with an electronic shaker at 250 rpm in 250mL conical flasks. In the adsorption 
isotherm tests, 0.5 g adsorbent was thoroughly mixed into 100 mL paracetamol solution in the 
range 200 to 700 ppm, while 0.5 g adsorbent was thoroughly mixed into 100 mL p-
aminophenol solution in the range 10 to 100 ppm. After the flasks had been shaken for 3 
hours, the solution was centrifuged for the separation of solid particles before 
spectrophotometric measurements of paracetamol and p-aminophenol. The mass of 
paracetamol and p-aminophenol adsorbed (Qe) was calculated in the same manner as in 
salicylic acid experiment (Section 3.3.1.6.2). 
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Chapter Four 
 
Identification of the Most Popular Drugs in Palestine 
 
4.1 Introduction 
 
Pharmaceuticals are used in large quantities throughout Palestine as prescription and non-
prescription drugs and they reach the environment. So the application of advanced membrane 
wastewater treatment plant to ensure an efficient removal of these pharmaceuticals from 
wastewater is considered very important. Hence the current study has been carried out and it is 
considered as the first study in Palestine. It is anticipated that this study will be a stepping 
stone for conducting other studies which may be devoted to the investigation of (1) the 
occurrence, fate and the concentration of these pharmaceuticals once arrived wastewater; (2) 
the quantitative information on pharmaceuticals concentrations in WWTPs effluents and their 
removal; and (3) the effect of human and animals medications on the environment (i.e. 
environmental risk assessment) in Palestine. 
 
4.2 Results and discussion 
 
The data in Table 4-1 was obtained from a research on 7000 Kupat Holeem Klalit members 
residing in Israel and East Jerusalem. In this search, Omri program was utilized to evaluate the 
top twenty consumed drugs in the year 2009. This data is applicable also for the Palestinian 
population due to the similarity in the use of drugs in the two regions. Table 4-1 lists a wide 
range of pharmaceutical classes including analgesics, vitamin supplements, anti-inflammatory 
compounds, antibiotics, anti-hypertensive agents, hypoglycemic agents, and lipid regulators 
[76]. 
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Table 4-1: List of the most top twenty consumed pharmaceuticals in Israel and East 
Jerusalem. 
  Drugs name 
Brand Name, (Generic Name), Dosage form 
 
Uses 
Vitacal®+ D (Calcium + vit D) Capsules Calcium deficiency 
Disothiazide® (Hydrochlorthiazide) Tablets Diuretic  
Metformin® (Metformin) Tablets Anti-diabetic agent 
Augmentin® (Amoxycillin + Clavulanic acid) Caplets Anti-bacterial  
Zinnat® (Cefixime) Tablets Anti-bacterial 
Micropirin®, Aspirin® (Acetylsalicylic Acid) Tablets Anti-coagulant 
Moxypen® (Amoxycillin) Syrup Anti-bacterial 
Fusid ® (Furosemide) Tablets Diuretic  
Tribemin ® (Vit B1, B2, B6) Tablets Vitamin-B deficiency 
Acamol® (paracetamol) Tablets Anti-pyretic and pain killer 
Ibufen® (Ibuprofen) Tablets Anti-inflammatory 
Ceforal® (Cephalexin) Capsules Anti-bacterial  
Normiten® (Atenolol) Tablets Anti-hypertension 
Omepradex® (Omeprazole) Capsules Against stomach ulcer 
Simvastatin® (Simvastatin) Tablets Lowering cholesterol 
Glibitic® (Glipizide) Tablets Anti-diabetic agent 
Optalgin® (Dyperone) Tablets Anti-pyretic and pain killer 
Enalpril® (Enalprilate) Tablets Anti-hypertension 
Bezafibrate® (Benzafibrate) Tablets Lowering triglycerides 
Amlodipine® (Amlodipine) Tablets Anti-hypertension 
 
Based on the above results, aspirin (acetylsalicylic acid, “ASA”) and paracetamol 
(Acetaminophen) were chosen as examples for testing our methodology for removing 
pharmaceuticals from wastewater. Both pharmaceuticals are widely sold as an over-the-
counter (OTC) and prescribed medications and therefore, they are anticipated to occur in 
wastewater influents. Some physicochemical properties of aspirin and its metabolite, salicylic 
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acid, and paracetamol, and its metabolite, p-aminophenol, are summarized in Table 4-2. 
Chapter 5 and 6 describes the fate of these pharmaceutical in wastewater and the efficiency of 
different wastewater treatment processes in removing them from environment.  
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Table 4-2: Physicochemical properties [78-79]. 
Properties Aspirin Salicylic acid Paracetamol 
(Acetaminophen) 
p-aminophenol 
 
 
Structure O
OH
O
O
aspirin  
 
HO
O
HO
salicylic acid  
 
O
N
H
OH
paracetamol
 
 
NH2HO
p-aminophenol  
Chemical formula C9H8O4 C7H6O3 C8H9NO2 C6H7NO 
Molecular weight (MW, 
g mol
-1
)  
 
180.16 
 
138.12 
 
 
151.16 
 
 
109.13 
Water Solubility (mgL
-1
),  
25 
o
C 
 
3000 
 
2000  
 
12742.7 
 
15000 
Log Kow 0.46 1.19 0.46-0.89 0.04 
pKa at 25 
o
C 3.49 2.98 9.5 5.75 
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Chapter Five 
 
Aspirin (Acetylsalicylic acid) 
 
5.1 Introduction 
 
Aspirin is a member of a family of chemicals called salicylates. It is chemically known as 
acetylsalicylic acid “ASA” and is commonly prescribed for its analgesic, antipyretic and anti-
rheumatic actions. In addition, aspirin is used once daily in low doses, 75 mg and 100 mg, as 
prophylactic medicine for the prevention of blood aggregation [62]. The latter (blood 
aggregation) is the most common cause for heart attack among people over the age of 40. 
Aspirin is among the top twenty medicines that have been found to be frequently used in East 
Jerusalem due to its activity as a pain killer [76].  
Aspirin is a white powder that is stable in dry conditions but is hydrolyzed to salicylic acid 
and acetic acid under humid or mist conditions (See Figure 5-1). Salicylic acid itself, which is 
derived naturally from willow tree bark, has also been used as an antipyretic since ancient 
times, and it is still used as an additive of some skin-care products and as a food preservative 
[59].  
 
O
O
O
H
O
H
CH3O
O
O
OH
O
OHH3C
Hydrolysis
Aspirin Salicylic Acid Acetic acid
RT, pH = 7
 
Figure 5-1: Hydrolysis of aspirin (acetylsalicylic acid) to salicylic acid and acetic acid. 
 
When aspirin is ingested, it is quickly and effectively hydrolyzed to the major excretion 
product, salicylic acid. Then, salicylic acid is metabolized primarily to two major inactive 
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metabolites: salicyluric acid (75%) arises from conjugation of salicylic acid with glycine, and 
glucuronide ether and ester (15%) arises from conjugation with glucuronic acid. In addition to 
these metabolites, small amounts of gentisic acid (1%) metabolites resulting from p-
hydroxylation mediated by cytochrome P450. These metabolites are then excreted in the 
urine. Only 5%-10% of a dose is excreted as free salicylic acid (See Figure 5-2) [80-81].  
 
The occurrence of aspirin was reported in treated wastewater in many countries around the 
world. Nakada and coworkers, reported that aspirin had the highest concentrations among 
other pharmaceuticals, ranging from 470 to 19400 ngL
-1
 in the sewage treatment plants (STPs) 
influents in Tokyo, Japan, and were removed efficiently during primary and secondary 
treatments (> 90% efficiency) [82]. Terns and coworkers reported average concentrations of 
salicylic acid in public owned wastewater treatment plants (POTWs), which received influents 
from both domestic, municipal, and industrial sewage system 54 µgL
-1
 influents and in 
effluents of 0.5 µgL
-1
 [83].  
The removal of salicylic acid (hydrolytic product of aspirin) has been studied by different 
research groups. Gagnon and coworkers studied the disinfection processes in terms of 
removing salicylic acid. They found that salicylic acid was eliminated at a rate greater than 
50% at an ozone dose of 10 mgL
-1
, and a higher rate (70%) was observed when 20 mgL
-1
 of 
ozone was used. The ozone technology is better than ultraviolet (UV) radiation in removing 
salicylic acid [84]. A high biodegradation of salicylic acid (>94%) during biologically 
activated sludge (BAC) process supported that salicylic acid was removed efficiently by BAC
 
[85]. Whereas according to Heberer (2002b), there are several other sources of salicylic acid 
in sewage, besides to the active metabolite of aspirin. These sources such as the use of 
salicylic acid as keratolytic, dermatice or preservative of food are even more likely to be 
responsible for the occurrence of this compound in the aquatic environment [59]. 
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Figure 5-2: Major metabolism pathways for aspirin. 
 
5.2 Calibration curve for Aspirin and Salicylic acid with extraction 
 
The calibration curve was obtained by plotting peak area versus concentration and is displayed 
in Figures 5-3 and 5-4 (ten data points) for aspirin and salicylic acid, respectively. They 
showed excellent linearity with correlation coefficient (R
2
) of 0.998 for aspirin and 0.999 for 
salicylic acid. This indicates that the method used is linear in the range of 0-200 ppm for both 
aspirin and salicylic acid. 
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Figure 5-3: A calibration curve for Aspirin. 
 
 
Figure 5-4: A calibration curve for Salicylic acid. 
 
5.3 Kinetic studies on the stability of aspirin in pure water and wastewater 
 
Since many pharmaceuticals might undergo degradation upon their standing in aqueous 
medium and wastewater environment, kinetic studies on aspirin in pure water and wastewater 
conditions have been undertaken. The kinetic results which were monitored by HPLC 
revealed that aspirin undergoes hydrolysis to salicylic and acetic acids (Figure 5-1). The rate 
of hydrolysis of aspirin is a function of temperature, amount of moisture present, and pH-
dependent. Figures 5-5 and 5-6 display the HPLC chromatograms of aspirin hydrolysis in pure 
water after 5 days incubation at 25
o
 C and of aspirin hydrolysis in the presence of wastewater 
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after 8 days at 25
o
 C, respectively. The peak at retention time of 4.3 minutes belongs to aspirin 
and that at 5.5 minutes to the hydrolysis product, salicylic acid. The kinetic data was 
examined for linear relationship. A linear correlation with a high correlation coefficient (R
2
) 
was found between ln [aspirin] (logarithms of aspirin concentration) and time. The correlation 
results obtained are illustrated graphically in Figure 5-7.  
In pure water, the linear correlation between ln [aspirin] and time is shown in Figure 5-7 (blue 
points) where the correlation coefficient (R
2
) was 0.9892. The rate constant for the hydrolysis 
of aspirin in pure water obtained from the slope of the plot in Figure 5-7 is 0.1104 s
-1
. While 
the first order rate of the hydrolysis of aspirin in pure water is 0.357 x 10
-8
 Ms
-1
. Similarly, 
kinetic study on the stability (hydrolysis) of aspirin in wastewater was conducted. The HPLC 
monitoring results for the hydrolysis of aspirin after incubation in wastewater for 10 days 
were examined for correlation-ship. The correlation of ln [aspirin] versus time gave a straight 
line with a correlation coefficient (R
2
) of 0.9532 as shown in Figure 5-7 (pink points). The 
first order rate calculated from the slope of the curve gave a value of 0.841 x 10
-8
 Ms
-1
. 
 
The following calculations of the initial rate of hydrolysis of aspirin in pure water and 
wastewater further illustrate this point. 
Rate of first order reaction = dC/dt = k [C] 
 
Concentration of aspirin = weight of aspirin/Molecular weight of aspirin in 1 liter = 500 ppm 
= 0.5g ÷ 180 = 0.00278 M. 
 
Initial Rate of the hydrolysis of aspirin in pure water at 25° C = 0.1104 x 0.00278 = 3.069 x 
10
-4 
M day
-1
 = (3.069 x 10
-4
)M/(24 x 60 x 60) sec = 0.357 x 10
-8
 Ms
-1
. 
Initial Rate of the hydrolysis of aspirin in the presence of wastewater at 25° C = 0.2617x 
0.00278 = 7.269x10
-4 
M day
-1
 = 7.269 x 10
-4 
M /(24 x 60 x 60) sec. = 0.841 x 10
-8
 Ms
-1
. 
 
The literature value for the rate constant for the hydrolysis of aspirin (Fersht and Kirby, 1967) 
at 39° C is 1.1 x 10
-5
 s
-1 
[86]. The initial rate at this temperature for the 500 ppm was equal to 
0.29 x10
-8
 Ms
-1
. This value is similar to that obtained in pure water and is significantly less 
than that in wastewater.  
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Figure 5-5: Chromatogram showing the hydrolysis of aspirin in pure water after 5 days. 
 
 
Figure 5-6: Chromatogram showing the hydrolysis of aspirin in presence of wastewater after 
8 days. 
 
 
46 
 
Figure 5-7: Plot of ln [Aspirin] vs. time (days). ▲ (Blue points) is for the hydrolysis of 
aspirin in pure water at 25
o
 C and ● (pink points) is for the hydrolysis of aspirin in the 
presence of wastewater at 25
o
 C. 
 
Comparison of the hydrolysis reaction rate values in pure water and in wastewater solution 
(0.357 x 10
-8
 Ms
-1 
vs. 0.845 x 10
-8
 Ms
-1
) revealed that the hydrolysis in wastewater proceeds at 
faster rate than in pure water. The accelerations in rate can be attributed to the content nature 
of the wastewater (consisting of variety of enzymes, bacteria and heavy metals) which can act 
as a catalyst for such reactions. 
 
5.4 The efficiency of membranes and activated carbon adsorbent in terms of removal of 
salicylic acid  
 
Since aspirin is not a stable chemical entity and undergoes a fast hydrolysis in the presence of 
wastewater, our goal was to find a suitable method for removing the aspirin hydrolyzed 
products, salicylic and acetic acids. It is known that acetic acid has a low boiling point and it 
is expected that within a short time of its formation will be evaporated. On the other hand, the 
solid non-volatile salicylic acid has to be removed by one of the well known filtration 
methods. Therefore, efforts in this research were concentrated on a membrane removal of the 
hydrolyzed product (salicylic acid) from wastewater samples rather than the removal of the 
parental drug (aspirin).  
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The use of membranes for wastewater treatment, especially coupling the membrane systems 
with other technologies such as pretreatment using activated sludge treatment process and/or 
ultrafiltration membranes followed by the use of reverse osmosis technologies could be the 
most efficient method in treating wastewater and removing a variety of pharmaceuticals [87].  
 
5.4.1 Salicylic acid wastewater spiking and sampling 
 
60 gram of salicylic acid standard was dissolved in a minimum amount of methanol then 
poured into the wastewater treatment plant (WWTP). Eight wastewater samples were collected 
from different locations of the wastewater treatment plant located at Al-Quds University main 
campus at Abu-Dies using pre-cleaned 500 ml glass containers. Figure 3-1 illustrates the 
sampling points (s.p.) which are as follows: Blank sample “before the addition of salicylic acid 
sample” (s.p. 1); AST ultrafiltration “hollow fiber” (AST-UF-HF) influent (s.p. 2) and effluent 
(s.p. 4), Nirosoft ultrafiltration “spiral wound”  (Nirosoft UF-SW) effluent (s.p. 6), activated 
carbon adsorbent effluent (s.p. 7), and reverse osmosis membrane effluent (s.p. 8). The eight 
samples were kept in an ice bath during transportation to the laboratory. Conventional 
wastewater parameters for the eight samples including total dissolved solids (TDS= 630 mgL
-
1
), temperature (27
o
 C), and pH were measured (pH= 7.3), then the samples were filtered and 
adjusted to pH < 2 by the addition of a few drops of concentrated hydrochloric acid (HCL) to 
improve the recovery for the acidic drug (salicylic acid), and then the sample was centrifuged 
for 15 minutes to remove suspended materials prior to extraction of acidic drugs, and then 
stored at 4
o 
C. The samples solutions were extracted by ether in order to clean up samples and 
this step is required in order to concentrate the target compound (salicylic acid) to a detectable 
level, and after evaporation were dissolved in mobile phase and analyzed by HPLC (see 
diagram in Figure 3-2). The results obtained are summarized in Table 5-1. 
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5.4.2 The efficiency of (UF-HF) and (UF-SW), activated carbon and RO membranes at 
the removal of salicylic acid.  
 
Figures 5-8, 5-9, 5-10 and 5-11 display the chromatograms of salicylic acid after passing 
through UF-HF, UF-SW membranes, activated carbon adsorbent, and reverse osmosis, 
respectively. Table 5-1 shows the efficiency of the removal of salicylic acid during 
ultrafiltration by hollow fiber (UF-HF), spiral wound (UF-SW), activated carbon adsorbent, 
and reverse osmosis. Examination of the results listed in Table 5-1 reveals that the efficiency 
of the hollow fiber and spiral wound ultrafiltration process is more than 70% (samples No. 4 
and 6) at the removal of salicylic acid in the effluent sample. The rejected salicylic acid was 
found and accumulated in the brine and concentrate of this machine. On the other hand, the 
efficiency for the removal of salicylic acid during activated carbon adsorbent is more than 
98% (Sample No. 7).  
 
The removal of salicylic acid from wastewater could rely on two types of processes which are 
based on mass transfer separtion accomplished by the transfer of mass from one phase to 
another (i.e. UF and RO membranes) and the sorption “i.e. adsorption” mechanism (activated 
carbon). It can be concluded that using a consequent system of the two types of UF 
membranes followed by activated carbon adsorbent is highly efficient to remove salicylic acid 
and hence there was no need to pass it through a reverse osmosis membrane. 
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Figure 5-8: Chromatogram showing the initial concentration of salicylic acid and after running 
the HF-UF (it represents the concentration of samples number 2 and 4, “see Figure 3-1”). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-9: Chromatogram showing the concentration of salicylic acid before and after 
running the SW-UF (it represents the concentration of samples number 4 and 6, “see Figure 3-
1”). 
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Figure 5-10: Chromatogram showing the concentration of salicylic acid after passing 
activated carbon adsorbent (it represents the concentration of samples number 6 and 7 “see 
Figure 3-1”).  
 
Figure 5-11: Chromatogram showing the concentration of salicylic acid before and after 
passing reverse osmosis (it represents the concentration of samples number 7 and 8 “see Figure 
3-1”).  
 
 
 
 
 
51 
Table 5-1: Performance of hollow fiber ultrafiltration (HF), spiral wound ultrafiltration (SW), 
activated carbon adsorbent, and reverse osmosis in terms of removal of salicylic acid from 
wastewater. 
Sample location 
number 
(See Figure 3-1) 
 
Name of sample location 
Concentration of 
salicylic acid (mg 
L
-1
) 
Sample No. 1 Blank (before addition 60 g of salicylic acid) 0 
Sample No. 2 Initial concentration of salicylic acid before 
running wastewater treatment plant 
54.30 
Sample No. 3 Brine of AST (ultrafiltration-hollow fiber) 38.62 
Sample No. 4 Product of AST (ultrafiltration-hollow fiber)  17.02 
Sample No. 5 Nirosoft (ultrafiltration-spiral wound fiber) 
“concentrate” 
14.43 
Sample No. 6 Permeate of Nirosoft (ultrafiltration-spiral 
wound fiber) 
11.42 
Sample No. 7 Product of activated carbon adsorbent  0.50 
Sample No. 8 Product of reverse osmosis 0.00 
 
5.5 Adsorption studies of salicylic acid onto a clay-micelle complex and powdered 
activated charcoal  
 
Adsorption mechanism depends on the physicochemical properties of the pharmaceutical and 
the aquifer media properties. Adsorption of salicylic acid onto a clay-micelle complex and 
pure activated charcoal adsorbents was investigated and described in this section. 
 
5.5.1 Calibration curve for salicylic acid using uv-visible spectrophotometer 
 
The calibration curve for salicylic acid was obtained by plotting absorbance of the drug versus 
its concentration, and is displayed in Figure 5-12. The results shown in the figure indicate an 
excellent linearity with a correlation coefficient (R
2
) of 0.999 which indicates that the method 
used is linear in the range of 0-100 ppm for salicylic acid. 
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.  
 
Figure 5-12: Absorbance versus concentration (mgL
-1) of salicylic acid (λ max = 295nm). 
 
5.5.2 Adsorption isotherm 
 
A clay micelle complex is prepared by mixing a specific type of a clay mineral 
(montmorillonite) with a cationic surfactant. In this study, octadecyltrimethylammonium 
(ODTMA) (Figure 5-13) with a critical micelle concentration (CMC) value of 0.3 mM was 
employed for a complex formation. A certain mass of clay was introduced into a solution of 
ODTMA until reaching a concentration of 1*10
-2
 M then stirred for 24 hours. The complex 
was filtered and dried then mixed with excess sand [77]. 
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Figure 5-13: Structure of Octadecyltriethylammonium (ODTMA). 
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Equilibrium relationships between adsorbents (i.e. clay-micelle complex and pure activated 
charcoal) and adsorbate (i.e. salicylic acid) are described by adsorption isotherms. The most 
common model for adsorption process is Langmuir adsorption isotherm. The latter is the most 
widely used for modeling equilibrium data and determination of the adsorption capacity [88]. 
Its linear form is represented by equation (1):  
 
  
     
 
        )   
  
                    
  
Where Ce is the equilibrium concentration of the pharmaceutical (salicylic acid) (mg L
-1
); Qe 
is the equilibrium mass of the adsorbed pharmaceutical (salicylic acid) per gram of complex 
(mg g
-1
); k is the Langmuir constant; and Qmax is the maximum mass of pharmaceutical 
(salicylic acid) removed per gram of complex (mg g
-1
) and it represents the adsorption 
capacity of the pharmaceutical onto adsorbents. 
Tables 5-2 and 5-3 list the initial and final equilibrium concentrations of salicylic acid 
obtained from the adsorption test. Also, the tables include the fixed mass of the clay-micelle 
complex and activated charcoal used in the test. Figure 5-14 shows a linear correlation 
between the terms Ce/Qe and Ce which indicates that the adsorption of salicylic acid onto the 
clay micelle complex and activated charcoal follows the Langmuir isotherm model.  
 
 
Figure 5-14: Langmuir isotherms for the removal of salicylic acid by a clay micelle complex 
(red point) and by powdered activated charcoal (blue points). 
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Qmax and k parameters for the removal of salicylic acid by the clay-micelle complex were 
determined from the slope and the intercept of (red points) shown in Figure 5-14. The 
calculated values of Qmax and k are shown in the following equations (2-3):   
 
                               
  
 
               
                                                     
 
Langmuir isotherm for the removal of salicylic acid by activated charcoal adsorbent was done 
in order to compare it with the efficiency for the removal by a clay-micelle complex. Blue 
points shown in Figure 5-14 describe the Langmuir isotherm for the removal of salicylic acid 
by charcoal. The calculated values of Qmax and k are shown in the following equations (4-5):  
 
                               
  
 
               
                                                     
 
Comparison between the calculated values of the Qmax for the adsorption of salicylic acid on 
the clay-micelle complex and activated charcoal reveals that both have comparable efficiency. 
However, since the quantity of the cationic surfactant in the clay-micelle complex is about 
three times smaller than the quantity of activated carbon in charcoal, so the adsorption 
efficiency of the clay micelle is much superior than activated charcoal. This complex by virtue 
of its positive charge with hydrophobic region is capable of binding negatively charged 
organic molecules and bacteria as well [77]. Meanwhile, from the results in Table 5-4, it can 
be observed that the activated carbon in charcoal has a higher capacity than the clay micelle 
complex in sorption of salicylic acid. This demonstrates that hydrophobic interactions are 
significant even for polar salicylic acid compound. 
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Table 5-2: Concentrations in equilibrium obtained for the adsorption test of salicylic acid onto the adsorbent clay-micelle complex 
used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 ml 
Conc. (final) 
(mgL
-1
), (Ce) 
Mass (final) 
(mg) 
M initial - M final; 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 Ce/Qe 
100 10 3.17 0.31 9.68 19.36 0.16 
150 15 5.55 0.55 14.44 21.66 0.19 
200 20 11.97 1.19 18.80 37.60 0.31 
250 25 26.48 2.64 22.35 44.70 0.59 
300 30 62.51 6.25 23.748 47.49 1.31 
400 40 126.11 12.61 27.38 54.77 2.23 
 
 
Table 5-3: Concentrations in equilibrium obtained for the adsorption test of salicylic acid onto the adsorbent powdered activated 
charcoal used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 ml 
Conc. (final) 
(mgL
-1
), (Ce) 
Mass (final) 
(mg) 
M initial - M final; 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 Ce/Qe 
100 10 2.45 0.24 9.75 19.50 0.12 
150 15 8.62 0.86 14.13 28.27 0.30 
200 20 22.65 2.26 17.73 35.46 0.63 
250 25 39.18 3.91 21.08 42.16 0.93 
300 30 64.61 6.46 23.53 47.07 1.37 
400 40 112.14 11.21 28.78 57.57 1.95 
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Table 5-4: Langmuir adsorption parameters (k and Qe), the square of correlation coefficient 
(R
2
) of salicylic acid onto both adsorbents. 
Pharmaceutical Adsorbents Langmuir sorption parameters 
 k Qmax (mg g
-1
) R
2 
Salicylic acid Clay micelle complex 0.15±0.0042 56.49±1.159 0.99±0.0022 
Powdered activated 
charcoal 
0.08±0.0.0197 60.60±1.156 0.98±0.0021 
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Chapter Six 
 
Paracetamol (Acetaminophen) 
 
6.1 Introduction 
 
Paracetamol was chosen for this study because it is widely used as an over-the-counter 
analgesic and antipyretic drug in Palestine. It is among the top twenty medicines that were 
found to be frequently used in East Jerusalem [76]. Also, it is heavily used all over the world 
[89].  
 
Paracetamol is metabolized primarily in the liver into non-toxic products. Three metabolic 
pathways are notable as shown in Figure 6-1. Glucuronidation is believed to account for 40% 
to 60% of the metabolism of paracetamol. Sulfation (sulfate conjugation) may account for 20–
40% [90]. N-hydroxylation and rearrangement, then Glutathione (gamma-glutamyl-L-
cysteinylglycine: GSH) conjugation, accounts for less than 15%. The hepatic cytochrome 
P450 enzyme system metabolizes paracetamol, forming a minor yet significant alkylating 
metabolite known as NAPQI (N-acetyl-p-benzo-quinone imine). NAPQI is then irreversibly 
conjugated with the sulfhydryl groups of glutathione. All three pathways yield final products 
that are inactive, non-toxic, and eventually excreted by the kidney. In the third pathway; 
however, the intermediate product NAPQI is toxic. NAPQI is primarily responsible for the 
toxic effects of paracetamol [80]. 
Paracetamol has been found with a concentration of up to 6 mg L
-1 
in European sewage 
treatment plants (STP) effluents [49] up to 10 mg L
-1 
in natural waters in USA [91], and even 
more than 65 mg L
-1 
in the Tyne River, UK. Furthermore, according to a reconnaissance study 
of organic wastewater contaminants in USA waters, paracetamol was determined to occur at a 
frequency of 23.8%  in surface water at a maximum concentration of 10 μgL-1 [49]. Recently 
removal of aqueous paracetamol by electrochemical [92], ozonation, H2O2-UV oxidation, and 
semiconductor photo catalysis have been reported for degradation of paracetamol [93]. 
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Figure 6-1: Metabolic pathways for paracetamol. 
 
6.2 Calibration curve for paracetamol and p-aminophenol.  
 
The calibration curve was obtained by plotting peak area versus concentration and is displayed 
in Figures 6-2 and 6-3 (seven data points) for paracetamol and p-aminophenol, respectively. 
The figures show excellent linearity with a correlation coefficient (R
2
) of 0.997 for 
paracetamol and 0.986 for p-aminophenol. This result indicates that the method used is linear 
in the range of 0-100 ppm for both paracetamol and p-aminophenol. 
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Figure 6-2: A calibration curve for paracetamol. 
 
 
Figure 6-3: A calibration curve for p-aminophenol. 
 
6.3 Kinetic studies on the stability of paracetamol in pure water and wastewater 
 
Paracetamol is available in different dosage forms: tablet, capsules, drops, elixirs, 
suspensions, and suppositories. Its saturated aqueous solution has a pH of about 6 and is stable 
(half-life over 20 years), meanwhile under abnormal conditions (heat, pH, temperature, etc.) 
its stability decreases and it degrades slowly forming a mixture of contaminants, such as p-
aminophenol and acetic acid, (Figure 6-4). This reaction could also be carried out by 
enzymatic cleavage or by microwave assisted alkaline hydrolysis of amide bond [90]. 
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Figure 6-4: Hydrolysis pathway for paracetamol. 
 
In a similar manner to that of aspirin, kinetic studies on paracetamol in pure water have been 
carried out at 25
o
 C. The kinetic results which were monitored by HPLC revealed that 
paracetamol was very stable in pure water due to the high activation energy needed to break 
down the amide bond. No degradation products were observed after incubation for more than 
two weeks as presented in Figures 6-5 and 6-6. 
 
 
Figure 6-5: Chromatogram of paracetamol after 0 day of incubation in pure water. 
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Figure 6-6: Chromatogram of paracetamol after 2 weeks incubation in pure water. 
 
On the other hand, HPLC monitoring of a solution of paracetamol in the presence of 
wastewater gave a gradual disappearance of a peak characterized as the reactant at a retention 
time of 3.92 minutes and a gradual appearance of a new peak at a retention time of 1.97 
minutes characterized as a degradation product. Figure 6-7 shows a representative 
chromatogram for the hydrolysis of paracetamol to products. Characterization of the 
compound that showed a peak at 1.97 minutes revealed that the hydrolyzed product of 
paracetamol is p-aminophenol. This result was supported by the fact that when a standard 
solution of p-aminophenol was injected to HPLC. Only one peak at a retention time of 1.97 
minutes was obtained. Figures 6-7 and 6-8 display the HPLC chromatograms of paracetamol 
in wastewater after 2 days incubation at 25
o
 C and the hydrolysis of paracetamol in presence 
of wastewater after 7 days at 25
o
 C, respectively. The hydrolysis of paracetamol in the 
presence of wastewater can be attributed to the content nature of the wastewater (consisting of 
variety of enzymes, bacteria and heavy metals, etc.) which can act as a catalyst for the 
cleavage of the amide bond (Figure 6-4).  
The kinetic data obtained from the HPLC monitoring (7 days) was examined for linear 
correlation. The correlation results indicates a linear correlation between ln [paracetamol] and 
time with a correlation coefficient (R
2
) = 0.8855 (Figure 6-9).  
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Figure 6-7: Chromatogram showing the hydrolysis of paracetamol after 2 days of incubation 
in presence of wastewater at 25
o 
C. 
 
 
Figure 6-8: Chromatogram showing the hydrolysis of paracetamol after 7 days of incubation 
in presence of wastewater at 25
o 
C. 
 
The rate constant for the hydrolysis of paracetamol obtained from the slope of the plot in 
Figure 6-9 is 0.6529 s
-1
. The initial rate of the hydrolysis of paracetamol in wastewater was 
calculated as follows: 
 
Concentration of paracetamol = weight of paracetamol/Mw of paracetamol in 1 liter = 200 
ppm = 0.20 g/151.1 = 1.323 x 10
-3
 M. 
Rate of first order reaction = dC/dt = k [C]. 
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Initial Rate of the hydrolysis of paracetamol in the presence of wastewater at 25°C = 0.6529 
M x 1.3230 x 10
-3
day = 8.6378 x10
-4 
M/day = 8.6378 x 10
-4
M /(24 x 60 x 60) sec = 1.0 x 10
-8
 
Ms
-1
. 
 
Figure 6-9:  Plot of ln [Paracetamol] vs. time (days) for the hydrolysis of paracetamol in the 
presence of wastewater at 25
o
 C. 
 
6.4 The efficiency of membranes and activated carbon adsorbent in terms of removal of 
paracetamol and p-aminophenol 
 
6.4.1 Paracetamol and its hydrolyzed product (p-aminophenol) wastewater spiking and 
sampling 
 
Samples of 25 gram of paracetamol and 25 gram of its hydrolyzed product (p-aminophenol) 
were dissolved in a minimum amount of methanol and were introduced to WWTP. Then, 
eight wastewater samples were collected from different locations of WWTP located in Al-
Quds University main campus at Abu-Dies using pre-cleaned 500 mL amber glass bottles. 
Samples from the sampling points 2, 4, 6, 7 and 8 (Figure 3-1) were collected for observing 
the membranes removal efficiency: ultrafiltration (hollow fiber and spiral wound), then 
followed by activated carbon and reverse osmosis membrane.  
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6.4.2 The efficiency of HF-UF (hollow fiber), SW-UF (spiral wound), activated carbon 
and RO membranes at the removal of paracetamol and p-aminophenol.  
 
Since paracetamol was found to undergo hydrolysis to p-aminophenol when kept standing for 
long time in wastewater we sought to study the efficiency of the different membranes on the 
removal of both paracetamol and p-aminophenol. Figures 6-10, 6-11, 6-12, and 6-13 display 
the chromatograms of concentration of paracetamol and p-aminophenol after passing HF-UF , 
SW-HF membranes, activated carbon adsorbent, and reverse osmosis, respectively. While 
Table 6-1 summarizes the results of the efficiency of HF-UF, SW-UF, activated carbon 
adsorbent and reverse osmosis membranes in removing paracetamol and p-aminophenol. 
Inspection of the results listed in Table 6-1 indicates that the efficiency of the ultrafiltration 
process is more than 40% (samples No. 4 and 6) at the removal of paracetamol and more than  
70% at that of p-aminophenol in the effluent samples. On the other hand, both the activated 
carbon adsorbent and the reverse osmosis membranes were significantly superior in the 
removal of paracetamol and p-aminophenol. In the case of acetaminophen a removal of 99% 
was observed by both membranes whereas a 100% removal was achieved when 4-
aminophenol was tested (Sample No. 7 and 8). 
 
 
Figure 6-10: Chromatogram showing the initial concentration of paracetamol and p-
aminophenol before and after running the HF-UF (it represents the concentration of samples 
number 2 and 4 “see Figure 3-1”). 
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Figure 6-11: Chromatogram showing the concentration of paracetamol and p-aminophenol 
before and after running SW-UF (it represents the concentration of samples number 4 and 6 
“see Figure 3-1”). 
 
 
Figure 6-12: Chromatogram showing the concentration of paracetamol and p-aminophenol 
before and after passing activated carbon adsorbent (it represents the concentration of samples 
number 6 and 7 “see Figure 3-1”). 
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Figure 6-13: Chromatogram showing the concentration of paracetamol and p-aminophenol 
before and after passing Reverse Osmosis (RO) membrane (it represents the concentration of 
samples number 7 and 8 “see Figure 3-1”). 
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Table 6-1: Performance of ultrafiltration hollow fiber (UF-HF), and ultrafiltration spiral wound (UF-SW), activated carbon 
adsorbent and reverse osmosis in terms of removal of paracetamol and p-aminophenol from wastewater. 
 
 
 
 
Sample location No.  
(See Figure 3-1) 
 
Sample location name 
Concentration of 
paracetamol (mg L
-1
) 
Concentration of p-
aminophenol (mg L
-1
) 
Sample No. 1 Blank (before addition of 25g paracetamol 
and p-aminophenol) 
 
0 
 
0 
Sample No. 2 Initial concentration of paracetamol and p-
aminophenol before running wastewater 
treatment plant 
20.95 24.3 
Sample No. 3 Brine of HF-Ultrafiltration 20.92 20.4 
Sample No. 4 Product of HF-Ultrafiltration  12.47 6.87 
Sample No. 5 SW-Ultrafiltration  “concentrate” 11.84 5.22 
Sample No. 6 Permeate of SW-Ultrafiltration 10.73 2.82 
Sample No. 7 Product of activated carbon adsorbent  0.223 0 
Sample No. 8 Product of reverse osmosis  0.01 0 
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6.5 Adsorption studies of paracetamol and p-aminophenol onto a clay-micelle complex 
and powdered activated charcoal. 
 
6.5.1 Calibration curve for paracetamol using UV-visible spectrophotometer.  
 
The calibration curve was obtained by plotting the absorbance of paracetamol versus its 
concentration and is illustrated in Figure 6-14. The Figure shows excellent linearity between 
the two variables with a correlation coefficient (R
2
) of 0.998. This indicates that the method 
used is linear in the range of 0-40 ppm for both paracetamol. 
 
 
Figure 6-14: Absorbance vs. concentration (mg L
-1
) of paracetamol (λmax = 243nm). 
 
6.5.2 Calibration curve  for  p-aminophenol using UV-visible spectrophotometer  
 
The calibration curve was obtained by plotting the absorption of p-aminophenol versus its 
concentration and is illustrated in Figure 6-15. The figure indicates excellent linearity with a 
correlation coefficient (R
2
) of  0.994.  
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Figure 6-15: Absorbance versus concentration mg L
-1 
of p-aminophenol (λmax = 195nm). 
6.5.3 Adsorption isotherm 
 
In a test similar to that conducted for salicylic acid, the sorption for the removal of 
paracetamol and its hydrolysis product p-aminophenol by a clay-micelle complex and 
powdered activated charcoal is well described by Langmuir adsorption isotherm as shown by 
the correlation of Ce\Qe versus Ce (Figure 6-16). Tables 6-2, 6-3, 6-4 and 6-5 list the initial 
and final equilibrium concentrations of both chemicals obtained from the adsorption test. 
Also, the tables include the fixed mass of the clay-micelle complex and powdered activated 
charcoal used in the test.  
 
The sorption of paracetamol and p-aminophenol onto both adsorbents are well fitted with 
langmiur sorption isotherm since the correlation coefficients for the Langmuir sorption of 
paracetamol and p-aminophenol were found in the range of 0.9921-0.9968 (Table 6-6). The 
calculated Qmax and k values for the removal of paracetamol by a clay-micelle complex are 
185.185 mg x g
-1
, 0.0325, respectively. The values for p-aminophenol are 15.33 mg x g
-1
 and 
0.461, respectively. The Langmuir isotherms for the removal of both chemicals by powdered 
activated charcoal gave Qmax values 129.87 mg x g
-1
 for paracetamol and 12.5 mg x g
-1
 for p-
aminophenol and the calculated k values were 0.35 for paracetamol and 4.82 for p-
aminophenol. Comparison of the calculated Qmax values of both chemicals using a clay-
micelle complex and powdered activated charcoal reveals that the former is more efficient 
than the later in removing paracetamol and p-aminophenol. 
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Figure 6-16: Langmuir isotherms for the removal of paracetamol and p-aminophenol by pure 
activated charcoal (blue points and purple points, respectively), and for removing paracetamol 
and p-aminophenol by a clay-micelle complex (red points and green points, respectively).  
 
The results can be explained by the mean of physicochemical properties of the organic drug, 
that is, water solubility and octanol-water partition coefficient (Kow). These properties can 
play a major role in the mobility of the drug in the subsurface adsorbents. The water solubility 
of paracetamol is 12,743 mg x L
-1
, while that of p-aminophenol is 15,000 mg x L
-1
. Moreover, 
p-aminophenol has a low log Kow of 0.04, while that of the paracetamol is higher (0.46), as 
shown in Table 4-2. p-Aminophenol with low Kow values tends to dissolve more readily in 
water than paracetamol, and thus tends to adsorb less. As a result, paracetamol shows greater 
sorption ability when compared to p-aminophenol in both adsorbents (Figure 6-16). In 
addition, it can be concluded that the adsorption of both chemicals onto activated charcoal 
surface is due mainly to dispersive forces causing the hydrophobic interaction between 
adsorbate and adsorbent. The hydrophobic part of pharmaceuticals tends to associate with the 
non-polar surface of activated carbon with the hydrophilic group directed toward the aqueous 
phase. Although the water solubility of these two pharmaceuticals is high, substantial sorption 
is still realized due to the hydrophobic part of both chemicals onto the non-polar surface of the 
activated carbon. The interactions caused by the affinity between polar and charged moieties 
of both organic compounds and a clay-micelle complex appear to play an important role in the 
sorption of those compounds onto this complex. 
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Table 6-2: Concentrations in equilibrium obtained for the adsorption test of paracetamol onto the adsorbent activated charcoal used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 mL 
Conc. (final) 
(mgL
-1
) (Ce) 
Mass (final) 
(mg) 
M initial - M final 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 (Ce)/(Qe) 
200 20 0.60 0.060 19.93 39.77 0.014 
300 30 1.58 0.15 29.84 59.68 0.02 
400 40 4.90 0.49 39.50 79.01 0.062 
500 50 14.32 1.43 48.56 97.13 0.147 
600 60 31.73 3.17 56.82 113.65 0.27 
700 70 62.18 6.21 63.78 127.56 0.48 
 
 
Table 6-3: Concentrations in equilibrium obtained for the adsorption test of paracetamol onto the adsorbent clay-micelle complex 
used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 mL 
Conc. (final) 
(mgL
-1
), (Ce) 
Mass (final) 
(mg) 
M initial - M final 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 (Ce)/(Qe) 
200 20 7.85 0.78 19.21 38.43 0.20 
300 30 13.69 1.36 28.63 57.26 0.23 
400 40 20.99 2.09 37.90 75.80 0.27 
500 50 30.91 3.09 46.90 93.81 0.32 
600 60 48.54 4.85 55.14 110.29 0.44 
700 70 64.12 6.41 63.58 127.17 0.50 
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Table 6-4: Concentrations in equilibrium obtained for the adsorption test of p-aminophenol onto the adsorbent clay-micelle complex 
used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 mL 
Conc. (final) 
(mgL
-1
) (Ce) 
Mass (final) 
(mg) 
M initial - M final 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 (Ce)/(Qe) 
10 1 0.30 0.03 0.03 0.06 0.15 
20 2 0.78 0.07 1.92 3.84 0.20 
30 3 1.24 0.12 1.75 3.51 0.21 
40 4 1.94 0.19 3.80 7.61 0.26 
50 5 3.40 0.34 4.65 9.31 0.36 
 
 
Table 6-5: Concentrations in equilibrium obtained for the adsorption test of p-aminophenol onto the adsorbent activated charcoal 
used. 
Conc. (initial) 
(mgL
-1
) 
Mass (initial) (mg) 
per 100 mL 
Conc. (final) 
(mgL
-1
) (Ce) 
Mass (final) 
(mg) 
M initial - M final 
(mg) 
Qe (mg g
-1
) = (M initial - M 
final) /0.5 (Ce)/(Qe) 
20 2 0.08 0.008 1.99 3.98 0.022 
30 3 0.21 0.021 2.97 5.95 0.035 
40 4 0.34 0.03 3.96 7.93 0.043 
50 5 0.76 0.07 4.92 9.84 0.077 
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Table 6-6: Langmuir adsorption parameters (k and Qe), the square of correlation coefficient 
(R
2
) of paracetamol and p-aminophenol onto both adsorbents. 
Pharmaceuticals Adsorbents Langmuir sorption parameters 
 K Qmax (mg g
-1
) R
2 
Paracetamol Clay micelle complex 0.032±0.0062 185.18±9.714 0.99±0.0048 
Powdered activated 
charcoal 
0.035±0.0.059 129.87±1.708 0.99±0.0014 
p-aminophenol Clay micelle complex 0.46±0.0550 15.33±0.216 0.99±0.0013 
Powdered activated 
charcoal 
4.81±1.624 12.50±1.143 0.99±0.0039 
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Chapter Seven 
 
 Conclusions and Recommendations  
 
7.1 Conclusions 
 
In summary, the key conclusions from this study are:  
 Both aspirin and paracetamol are not stable in wastewater conditions and they undergo a 
relatively fast hydrolysis to the corresponding hydrolysis products. Therefore, efforts should 
be concentrated on finding suitable methods for the removal of salicylic acid (aspirin product) 
and p-aminophenol (paracetamol product) rather than to focus on the parental drug. 
 
 The efficiency of hollow fiber and spiral wound membranes at the removal of the 
pharmaceutical studied herein (paracetamol and aspirin) is not satisfactory (40-70%), whereas, 
the activated carbon, clay micelle complex and reverse osmosis membranes were completely 
efficient in removing both pharmaceuticals (about 100%). Hence, we conclude that a clay 
micelle complex and activated carbon filters can effectively remove pharmaceuticals of the 
kind described herein and there is no need to use more expensive methods such as a reverse 
osmosis membrane. 
 
 Clay-micelle complex and powdered activated charcoal are considered to be effective 
methods for the removal of aspirin, paracetamol, and their degradation products from aqueous 
solution because both membranes characterized by a large surface area, micro-porous nature, 
high adsorption capacity, and easy availability.  
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 7.2 Recommendations 
 
The following recommendations are considered important regarding the efficiency of 
advanced membrane wastewater treatment plant towards the removal of pharmaceuticals in 
Palestine: 
 
 Palestine, in particular, suffers from water shortage and poor water quality, so wastewater 
treatment and reuse as a reliable source of fresh water is essential to be adopted by the 
Palestinians to meet future needs in a sustainable way.  
 
 The municipalities should construct wastewater treatment plants especially in industrial, 
agricultural, and hospital areas using advanced membrane technologies instead of traditional 
wastewater treatment pools. This is because it is efficient in terms of the removal of traces of 
pharmaceuticals. 
 
 Further studies are recommended to be elaborated on the occurrence, fate, and 
concentration of pharmaceuticals. In addition more elaboration on the investigation of the 
effect of PPCPs on the environment (environmental risk assessment) and human risk 
assessment should be considered. 
 
 Educating the general public in the Palestinian society on how the pharmaceuticals should 
be disposed in order to prevent their entry into the environment. This can be done by raising 
the awareness towards the household disposal of unused and expired pharmaceuticals.  
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ه الصزف الصحي في إسالت دراست مذى مفاءة إسخخذام حقنيت الأغشيت المخقذمت في محطت معالجت ميا
  أمينوفينوه-الباراسيخاموه وباراو "الصفصاف"حامض الساليسيليل  و الأسبزيه
 
 .فاطمت شفيق موسي عياش: إعذاد
 
 .مصطفي خميس. د.رفيق قزمان ، أ. د.أ: إشزاف
 
 
 : الُمل ًّخًّص
 
ٚخُأل يٕضٕع ْزا انبحث دساست حكُٕنٕجٛا انفصم انحاجض٘ بإسخخذاو الأغشٛت انًخقذيت نًؼانجت يٛاِ انصشف انصحٙ 
كفاءحٓا فٙ إصانت انًٕاد انصٛذلاَٛت، ٔححهم يٕادْا ٔانًٕاد الأٚضٛت انخابؼت نٓا يٍ انًٛاِ فٙ فحص يذٖ ) انًٛاِ انؼاديت(
ٔيادة " انصفصاف"ُٔ ِجذ أ ٌّ الأسبشٍٚ ٔانباساسخٛايٕل كلاًْا ٚخحهُم فٙ انًٛاِ انؼاديت ُٔٚخجا حايض انسانٛسٛهٛك . انؼاديت
فٙ انًٛاِ انؼاديت حى ) الأسبشٍٚ ٔ انباساسٛخايٕل(  انذٔايٍٛإ ٌّ سشػت حفاػم ححهّم كلا. ايُٕٛفُٕٛل، ػهٗ انخشحٛب -باسا
* 548.0فحصٓا ٔدساسخٓا، ٔ ُٔ ِجذ أَٓا يٍ حفاػلاث انذسجت الأٔنٗ بثابج ُيؼّذنّ ُيسا ٍٔ نـِ 
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ْزِ انقٛى كاَج أػهٗ فٙ انًقذاس يٍ حهك انخٙ  حٛث إٌ. ثاَٛت فٙ دسجت حشاسة انغشفت انؼادٚت، نكم يُٓا ػهٗ انخشحٛب/يٕل
ٔكزنك إٌ الأداء انؼاو نًحطت يؼانجت انًٛاِ انؼاديت كاٌ قذ أظٓش كفاءة . حخحهم ػهٛٓا فٙ انًٛاِ انُقٛت ححج َفس انظشٔف
فاءة فٙ ٔكاَج انًٕاد الأكثش فؼانٛت ٔك .حذٔد انكشف بانًُٓج انخحهٛهٙٔاضحت فٙ إصانت حهك انًٕاد ٔبشكم كايم ٔضًٍ 
 )tnebrosda nobrac detavitca(  إصانت حهك انؼقاقٛش داخم يحطت انًؼانجت ْٙ يادة انكشبٌٕ انًُشط راث انسطح انًاص 
حى دساست أٚضٔثشياث  ٔكًا ٔقذ .)xelpmoc ellecim-yalc(ٔيادة يشكب يٛسم انّصهصال انًؼقذ 
نٓزِ انًٕاد بإسخخذاو كم يٍ انكشبٌٕ انًُشط ٔيادة إيخضاص ُيطّٕسة حذٚثاً حُسًٗ  )smrehtosi noitprosda(الإيخضاص
 riumgnaL(كم الأٚضٔثشياث انخٙ حى دساسخٓا  ُٔ جذ بإَٓا حخطابق يغ أٚضٔثشو لاَكًاٚش. يشكب يٛسم انصهصال انًؼقذ
حى حقًٛٛٓا  )yticapac noitprosda(ٔقابهٛت الايخضاص)  )tnatsnoc riumgnaL، ٔكًا إٌ ثابج لاَكًاٚش )mrehtosi
 .ٔيُاقشخٓا ُْا
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